Efficacy of Ivy Leaf Extract Syrup in Managing Bronchial Asthma Among Children: A Prospective Observational Study

Authors

  • Ana Maqbool Department of Pediatrics, Umm e Ilyas Hospital, Rawalakot, Azad Jammu and Kashmir, Pakistan Author
  • Muhammad Zakryya Khan Assistant Professor, Department of Biology, International Islamic University, Islamabad, Pakistan image/svg+xml Author
  • Sania Begum Principal Lab/Scientist, Department of National Institute for Genomics and Advanced Biotechnology NIGAB, NARC, Islamabad, Pakistan Author
  • Asia Kiran Institute of Molecular Biology & Biotechnology, University of Lahore, Lahore, Pakistan image/svg+xml Author

DOI:

https://doi.org/10.62497/irabcs.132

Keywords:

Bronchial asthma, ivy leaf extract, children, herbal therapy, asthma control, pediatric respiratory care

Abstract

Background: Bronchial asthma is a common chronic respiratory disorder in children, and there is growing interest in exploring herbal therapies such as ivy leaf extract for symptom relief.

Objective: To evaluate the clinical efficacy and safety of dry extract of ivy leaves in children aged 7 to 12 years diagnosed with mild to moderate bronchial asthma.

Methodology: This prospective observational study was conducted at the Department of Pediatric Medicine, Pakistan Institute of Medical Science (PIMS), Islamabad, in collaboration with the International Islamic University, Islamabad, from August 2023 to July 2024. A total of 120 children with clinically stable bronchial asthma were enrolled using convenience sampling. All participants received a standardized dry ivy leaf extract syrup at a total daily dose of 105 mg, administered in age-appropriate doses for four weeks. Asthma symptoms were assessed using a standardized pediatric asthma control scoring tool at baseline and post-treatment. Adverse effects were monitored using structured checklists and open-ended questionnaires completed by caregivers. Statistical analysis was performed using SPSS version 26.0, with paired t-tests to assess symptom changes.

Results: The mean weekly frequency of daytime symptoms decreased from 4.58 ± 1.42 to 2.01 ± 1.18 (p<0.001), nocturnal awakenings reduced from 2.77 ± 1.11 to 1.05 ± 0.84 (p<0.001), and limitation in physical activity improved from 3.20 ± 1.03 to 1.35 ± 0.76 (p<0.001). Full compliance was observed in 108 (90.00%) patients. Adverse effects were minimal, with 84.17% reporting no issues.

Conclusion: Dry ivy leaf extract appears to be an effective and well-tolerated adjunct treatment for symptom relief in pediatric bronchial asthma.

Downloads

Download data is not yet available.

Author Biographies

  • Ana Maqbool , Department of Pediatrics, Umm e Ilyas Hospital, Rawalakot, Azad Jammu and Kashmir, Pakistan

    Department of pediatrics, Umm e ilyas  Hospital, Rawalakot, Azad Jammu and Kashmir, Pakistan

  • Muhammad Zakryya Khan, Assistant Professor, Department of Biology, International Islamic University, Islamabad, Pakistan

    Department of biotechnology

    International Islamic university  Islamabad (IIUI) 

References

Bereda G. Bronchial asthma: etiology, pathophysiology, diagnosis and management. Austin J Pulm Respir Med. 2022;9(1):1085. https://www.researchgate.net/profile/Gudisa-Bereda/publication/360458025_Gudisa_Basthma/links/6277ff25973bbb29cc6d65a7/Gudisa-Basthma.pdf.

Beran D, Zar HJ, Perrin C, Menezes AM, Burney P. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. The Lancet Respiratory Medicine. 2015 Feb 1;3(2):159-70. DOI: 10.1016/S2213-2600(15)00004-1 .

Vitale C, Maglio A, Pelaia C, Vatrella A. Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy. Expert Opinion on Pharmacotherapy. 2017 May 3;18(7):667-76. https://doi.org/10.1080/14656566.2017.1317747

George M, Topaz M. A systematic review of complementary and alternative medicine for asthma self-management. The Nursing Clinics of North America. 2013 Jan 10;48(1):10-16. doi: 10.1016/j.cnur.2012.11.002.

Sierocinski, E., Holzinger, F. & Chenot, JF. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol 77, 1113–1122 (2021). https://doi.org/10.1007/s00228-021-03090-4

Shokry A, El-Shiekh R, Kamel G, Ramadan A. Phytochemical contents, biological activities and therapeutic applications of hedera helix (ivy leaf) extracts: a review. The Natural Products Journal. 2022 Jul 1;12(4):22-32. https://doi.org/10.2174/2210315511666210917111801.

Kamin W, Seifert G, Zwiauer K, Bonhoeffer J, De Ketelaere V, D'Avino A, Štádler J, Bustamante-Ogando JC, Kara A. Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review. Frontiers in Pediatrics. 2025 May 1;13:1423250. https://doi.org/10.3389/fped.2025.1423250.

Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (hedera helix) for acute upper respiratory tract infections. Evidence‐Based Complementary and Alternative Medicine. 2011;2011(1):382789. https://doi.org/10.1155/2011/382789

Lang C, Röttger-Lüer P, Staiger C. A valuable option for the treatment of respiratory diseases: review on the clinical evidence of the ivy leaves dry extract EA 575®. Planta medica. 2015 Aug;81(12/13):968-74. DOI: 10.1055/s-0035-1545879.

Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011 Oct 15;18(13):1105-9. https://doi.org/10.1016/j.phymed.2011.06.014.

Hofmann D, Hecker M, Völp A. Efficacy of dry extract of ivy leaves in children with bronchial asthma–a review of randomized controlled trials. Phytomedicine. 2003 Jan 1;10(2-3):213-20. https://doi.org/10.1078/094471103321659979

Kruttschnitt E, Wegener T, Zahner C, Henzen-Bücking S. Assessment of the efficacy and safety of ivy leaf (Hedera helix) cough syrup compared with acetylcysteine in adults and children with acute bronchitis. Evidence‐Based Complementary and Alternative Medicine. 2020;2020(1):1910656. https://doi.org/10.1155/2020/1910656.

Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011 Oct 15;18(13):1105-9. https://doi.org/10.1016/j.phymed.2011.06.014.

Pourova J, Dias P, Pour M, Fialová SB, Czigle S, Nagy M, Tóth J, Balázs VL, Horváth A, Csikós E, Farkas Á. Proposed mechanisms of action of herbal drugs and their biologically active constituents in the treatment of coughs: an overview. PeerJ. 2023 Oct 24;11:e16096. https://peerj.com/articles/16096/.

Baharara H, Moghadam AT, Sahebkar A, Emami SA, Tayebi T, Mohammadpour AH. The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review. Adv Exp Med Biol. 2021;1328:361-376. doi: 10.1007/978-3-030-73234-9_23

Vogelberg C, Seifert G, Braun S, Zingel R, Kostev K. The Impact of Ivy Leaf Dry Extract EA 575 on Subsequent Antibiotic Use and Its Therapeutic Value in Children and Adolescents with the Common Cold: A Retrospective Prescription Database Analysis. Children. 2025 Apr 17;12(4):518. https://doi.org/10.3390/children12040518

Seifert G, Upstone L, Watling CP, Vogelberg C. Ivy leaf dry extract EA 575 for the treatment of acute and chronic cough in pediatric patients: Review and expert survey. Current Medical Research and Opinion. 2023 Oct 3;39(10):1407-17. https://doi.org/10.1080/03007995.2023.2258777

Downloads

Published

07/27/2025

Issue

Section

Research Articles

Categories

How to Cite

1.
Maqbool A, Khan MZ, Begum S, Kiran A. Efficacy of Ivy Leaf Extract Syrup in Managing Bronchial Asthma Among Children: A Prospective Observational Study. IRABCS [Internet]. 2025 Jul. 27 [cited 2025 Aug. 31];3(1):41-5. Available from: https://irjpl.org/irabcs/article/view/132

Similar Articles

11-20 of 44

You may also start an advanced similarity search for this article.